E ndovascular coil embolization has become a widely performed procedure for the treatment of cerebral aneurysms. The purpose of this treatment is to prevent the cerebral aneurysm from rupturing. Although this procedure has both low morbidity and mortality rates, late recanalization and rupturing of coiled aneurysms are both major concerns with their inherent risks and costs.
sign (WCS)
. 3 This sign means the complete separation between aneurysm sac and parent artery, which may indicate the healing of the aneurysm. However, the nature of the WCS is not well known in humans. Moreover, the longterm result in patients with WCS has never been reported. The purpose of this study was to evaluate factors in the appearance of WCS and to identify radiological and clinical outcomes of treated aneurysms with WCS.
Methods

Study Population
We conducted a retrospective study of patients with saccular intracranial aneurysms treated by endovascular coil embolization between April 2011 and December 2013. A total of 201 consecutive patients with 211 saccular intracranial aneurysms were treated by endovascular coil embolization (Fig. 1) . From this group 51 aneurysms were excluded because it was impossible to detect the aneurysm neck between the lesion's sac and the parent artery clearly by using conventional digital subtraction angiography (DSA) as aneurysms involving the parent artery. In addition, 11 aneurysms were lost to follow-up. Therefore, 140 patients (29 men, 20.7%; mean age 58.6 ± 12.9 years) with 149 intracranial aneurysms were included in this study. A total of 119 aneurysms were unruptured and 30 aneurysms were ruptured. The aneurysm characteristics were retrospectively examined by reviewing the medical records. This study was approved by the hospital ethics committee.
Endovascular Procedures
In cases of unruptured aneurysm, coil embolization was performed under local or general anesthesia according to the location and size of the aneurysm. Patients with a ruptured aneurysm underwent treatment using general anesthesia. The coils used in the treatment were bare platinum coils, bioactive coils (Cerecyte [Micrus Endovascular] or Matrix2 [Stryker]), or hydrogel coils (Hydrocoil [MicroVention, Inc.]). These coils were selected by the surgeon on a patient-by-patient basis. Balloon remodeling or stent-assisted technique was performed according to the aneurysm size, neck size, location, and clinical presentation (ruptured or unruptured). The Enterprise VRD (Codman) or the Neuroform (Stryker) stent was used for the stent-assisted coil embolization. The percentage of packing density was calculated as the ratio of coil volume to aneurysm volume × 100. Patients with unruptured aneurysms received a dose of dual antiplatelet medication (100 mg aspirin and 75 mg clopidogrel) 1 week before the procedure. Patients with ruptured aneurysms received a dose of single antiplatelet medication (100 mg aspirin) on the day of the procedure. The dual antiplatelet medication was maintained for 1-3 months and then changed to aspirin monotherapy for 3-6 months in patients with unruptured lesions without a stent, and aspirin monotherapy was continued indefinitely in patients with unruptured aneurysms who had a stent. Aspirin monotherapy was maintained for 3-6 months in patients with ruptured aneurysms. All endovascular treatments were performed by 5 interventionalists (T.H., K.F., M.O., M.I., and T.Y.). The status of postembolization lesions was evaluated based on the Raymond grading scale.
13
Evaluation of WCS Follow-up angiography was conducted mainly at 6 months (range 5-12 months). A WCS was defined as the appearance of a radiolucent separation at the aneurysm neck between the coil mass and the parent artery on DSA and on nonsubtracted images at follow-up angiography (Fig. 2) . So, the embolization status of an aneurysm with WCS corresponded to complete occlusion. All angiographic imaging studies were acquired using a biplane flat-panel detector (FPD) angiographic system (Artis zee BA Twin, Siemens AG). The C-arm angle was set to clearly observe the neck of the aneurysm between the aneurysm sac and the lumen of the parent artery. The images were acquired in a 1024 × 1024 matrix by using a 22-cm field of view (FOV) FPD or a 720 × 720 matrix by using a 16-cm FOV FPD and were then evaluated on a workstation (syngo X-Workplace, Siemens AG). Image edge enhancement was adjusted to correct for the coil artifact influence. Nonionic iodinated contrast material (Iopamiron 300, Bayer Healthcare Japan) was injected manually at a flow rate of 2.5-3.5 ml/second (5-7 ml of total volume). These angiographic conditions were the same at the time of treatment and at the 6-month followup period.
Outcome Assessment
Clinical and radiological follow-up investigations were performed every 6-12 months in each patient. Radiological examination was performed using MR angiography (MRA). The MRI studies were acquired using a 1.5-T unit (Achieva or Ingenia, Philips Medical Systems). Imaging parameters of MRA using a 3D time of flight technique were TR 25.0, TE 6.9, 15° flip angle, 150 × 150-mm FOV, 512 × 512 matrix, and 0.6-mm effective thickness. Cases with stent-assisted coil embolization were excluded from this analysis because stent artifacts prevent accurate assessment of embolization status using MRA. Clinical outcome was evaluated whether the rupture occurred in an unruptured aneurysm or was the rerupture of a ruptured aneurysm. The status of a coiled aneurysm on initial postembolization angiography, at the follow-up angiography including WCS determination, and at the follow-up MRA was analyzed by 2 neurointerventionalists (T.H. and K.F.). When there was any discrepancy, a decision was made by another neurointerventionalist (M.I.).
Statistical Analyses
Statistical analyses were performed using SPSS software (IBM). Categorical variables are presented as number and percentage, and continuous variables are presented as the mean ± SD. The chi-square test or Fisher exact test was performed to analyze categorical variables as appropriate. Where necessary, an independent t-test or the Mann-Whitney U-test was used for unpaired continuous variables, and a paired t-test or Wilcoxon signed-rank sum test was used for paired continuous variables. Multivariate logistic regression analysis was performed to identify factors associated with the appearance of a WCS. These factors were selected according to the reported factors of aneurysm recurrence: the neck size, the aneurysm size, hemorrhagic presentation, packing density, and the incomplete initial occlusion status. 10, 12, 14, 15 To ascertain the continuous value from multivariate analysis as the cutoff point for the prediction of the appearance of a WCS, receiver operating characteristic (ROC) curve analyses were also performed. Differences were defined as significant at a probability level of p < 0.05.
Results
Patient and Aneurysm Characteristics
The characteristics of the study population are listed in Table 1 : 140 patients (29 men [20.7%], mean age 58.6 ± 12.9 years) with 149 intracranial aneurysms were analyzed. A total of 119 aneurysms (79.9%) were unruptured, and 30 aneurysms (20.1%) were ruptured. There were no significant differences in the frequency of conventional risk factors between the unruptured and ruptured groups. The average aneurysm size was 5.7 ± 2.2 mm (range 2.4-16.0 mm), the average aneurysm neck size was 4.1 ± 1.1 mm (range 1.8-8.2 mm), and the average dome-to-neck ratio was 1.3 ± 0.3 (range 0.8-2.0). The neck size was significantly larger in the unruptured group than in the ruptured group (4.2 ± 1.1 mm vs 3.6 ± 1.1 mm, p = 0.02). The aneurysm size and dome-to-neck ratio were similar in both groups. Aneurysms on the anterior communicating artery (ACoA) and anterior cerebral artery (ACA) were more frequent in the ruptured group (66.7% vs 16.0%), whereas aneurysms on the internal carotid artery (ICA), middle cerebral artery (MCA), and vertebral artery/basilar artery (VA/BA) were more frequent in the unruptured group (p < 0.001).
Factors of WCS Appearance
A WCS was confirmed in 23 of 149 cases (15.4%) mainly at 6-month follow-up angiography (range 5-6 months) ( Table 2 ). In univariate logistic regression analysis, no significant difference was observed between the WCS-positive and WCS-negative groups in any of the following characteristics: age; sex; aneurysm location; type of aneurysm (sidewall type or bifurcation type); rupture status (unruptured or ruptured); initial embolization status (complete occlusion, residual neck, or residual aneurysm); packing density; coil variety (use of bioactive coil or hydrogel coil); or stent use. However, the WCS-positive group had significantly smaller neck size (3.3 ± 0.8 mm vs 4.2 ± 1.1 mm, p < 0.001) and smaller aneurysm size (4.3 ± 0.9 mm vs 6.0 ± 2.1 mm, p < 0.001) compared with the WCS-negative group. In multivariate logistic regres- sion analysis, the independent predictor of a WCS was a small neck (OR 0.376, 95% CI 0.179-0.787; p = 0.009) ( Table 3 ). In the ROC curve analysis, a neck size of 4.1 was determined as the most reliable cutoff value for predicting the appearance of a WCS (95% CI 0.662-0.846) (Fig. 3) . Based on this cutoff value, the sensitivity and specificity were 87.0% and 51.6%, respectively. The positive and negative predictive values were 24.7% and 95.6%, respectively. Of 126 aneurysms without WCS, the angiography showed complete occlusion in 56 aneurysms (44.4%), the residual neck in 62 (49.2%), and residual aneurysm in 8 (6.3%), mainly at 6-month follow-up (range 5-12 months). Compared with the complete occlusion aneurysms without WCS, the WCS-positive aneurysms had significantly smaller neck size (3.3 ± 0.8 mm vs 4.2 ± 0.9 mm, p < 0.001) and smaller aneurysm size (4.3 ± 0.9 mm vs 5.7 ± 1.8 mm, p < 0.001).
Radiological and Clinical Outcomes
The radiological and clinical results of coiled aneurysms were analyzed after the evaluation of WCS. Fortythree aneurysms were excluded because they were treated with stents. Therefore, 106 of 149 aneurysms were analyzed at a mean follow-up of 31.0 ± 9.7 months (range 5-52 months). The rate of complete occlusion was significantly higher in the WCS-positive group (18/18, 100%) than in the WCS-negative group (54/88, 61.4%; p = 0.001) ( Table  4 ). The overall major recanalization rates are low for both the WCS-positive and -negative groups (0/18, 0% vs 6/88, 6.8%; p = 0.254). Retreatment was performed in those 6 patients at 5-26 months. No rupture occurred in any patient in this period.
Patients with complete occlusion without the WCS at 6-month follow-up also had good radiological and clinical outcomes. Complete occlusion was maintained and no rupture occurred in any patient.
Discussion
A WCS is a radiolucent gap between the coil mass in the aneurysm and the lumen of the parent artery observed on angiography between 14 days and 6 months after endovascular coil embolization, which indicates a formation of thick neointimal tissue at the neck of the aneurysm. 9 Gonzalez et al. first reported the appearance of WCS in human beings for 2 cases of cerebral aneurysms. 3 However, the prognosis of a coiled aneurysm with WCS is unknown. This is the first study to evaluate the role of WCS in the radiological and clinical outcome. In our study, the presence of a WCS was confirmed in 15.4% of cerebral aneurysms at 5-6 months after endovascular coil embolization. The most important factor in the appearance of WCS was small neck size. The appearance of a WCS was not correlated with either the location of the aneurysm or the initial angiographic status. A previous study has demonstrated that the rate of a WCS appearance was 6.9%, and that a small neck correlated with the appearance of WCS only in cases of unruptured aneurysm. 4 Our study revealed that WCS tended to appear in the smallnecked aneurysms after treatment in both unruptured and ruptured aneurysms. Furthermore, the WCS-positive aneurysms had significantly smaller neck size and smaller aneurysm size compared with the aneurysms with complete occlusion without WCS. The neointimal thickening would be promoted at the neck of these coiled aneurysms, which prevents any further aneurysmal filling. Although bioactive coils were developed to prevent the recurrence of aneurysm by promoting organized thrombus formation and growth of connective tissue into the aneurysm, 1,9 they were not associated with the appearance of WCS in our study. Recent randomized trials revealed that bioactive or hydrogel coils were not associated with prevention of major recurrence of aneurysm when compared with bare platinum coils. 6, 8, 18 Our study also demonstrated that the outcome of treated aneurysms with WCS was excellent in the follow-up period. Complete occlusion was maintained at an average of 31 months in all cases with a WCS. Neither major recanalization nor aneurysm rupture occurred. Factors of aneurysm recurrence were reported to be a neck size > 4 mm, an aneurysm size > 10 mm, initial angiographic status, and a hemorrhagic presentation. 10, 12, 14, 15 The rate of retreatment for previously coiled aneurysms was reported as 6%-33%, whereas that of aneurysm rupture was very low. 7, 13, 14, 18 Consistent with a previous histological study, 9 our study supposed that WCS would indicate a healing of the aneurysm. The prognosis of coiled aneurysms will be confirmed by evaluating WCS.
A limitation of this study is that the average aneurysm size of 5.7 mm in our sample was relatively small. This is because larger aneurysms tend to involve the parent artery, and the precise confirmation of the neck between aneurysm and parent artery is difficult achieve by conventional angiography, which is unable to evaluate WCS. Indeed, 51 of 211 saccular aneurysms were excluded for that reason in this study. Also, cases with stent treatment were excluded in the radiological outcome of WCS because the embolization status could not be evaluated due to the stent artifact on MRA. Stent-assisted coil embolization tends to be performed for wide-necked aneurysms (neck size is one of the risk factors for recanalization). 11 So, the rate of major recanalization was low and the clinical result was excellent in both WCS-positive and WCS-negative cases in this study.
A previous study has reported that the stability of embolization status was decided mainly at 6 months. 16 The prognosis of coiled aneurysms with adequate occlusion (complete occlusion or small neck remnant) at 6 months was expected to be excellent. After 6 months, the factors of late recanalization were the presence of intraluminal thrombus and aneurysm size > 15 mm. 2 Therefore, we could not detect the difference between cases of complete occlusion with and without WCS according to the radiological and clinical outcomes, which were both excellent. Our study was also retrospective in nature. Despite these limitations, this study focused on the role of WCS and revealed that WCS is one of the reliable markers for the long-term stability of complete occlusion after endovascular embolization of saccular aneurysms, which would lead to a good clinical outcome. In the future, a large prospective study will be necessary to confirm the clinical importance of WCS.
Conclusions
A WCS appeared in 15.4% of aneurysms after endovascular coil embolization. The significant factor in the appearance of WCS was a small-necked aneurysm. The WCS was associated with the maintenance of complete occlusion. The WCS would be a good predictor of radiological and clinical outcome.
